SEC Comment Letter for GSK (GSK) — Feb 21, 2006
GSK plc
Date: Feb. 21, 2006 · CIK: 0001131399 · Accession: 0000000000-06-008727
AI Filing Summary & Sentiment
Letter
Via Facsimile Mail Stop 6010 February 13, 2006 Mr. J.P. Garnier Chief Executive Officer GlaxoSmithKline PLC 980 Great West Road Brentford, Middlesex TW8 9GS England
Re: GlaxoSmithKline PLC Form 20-F for Fiscal Year Ended December 31, 2004 Filed March 8, 2005 File No. 1-15170
Dear Mr. Garnier:
We have completed our review of your Form 20-F and related filings and have no further comments at this time.
Sincerely,
Jim B. Rosenberg
Senior Assistant Chief
Accountant
??
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Via Facsimile
Mail Stop 6010
February 13, 2006
Mr. J.P. Garnier
Chief Executive Officer
GlaxoSmithKline PLC
980 Great West Road
Brentford, Middlesex
TW8 9GS England
Re: GlaxoSmithKline PLC
Form 20-F for Fiscal Year Ended December 31, 2004
Filed March 8, 2005
File No. 1-15170
Dear Mr. Garnier:
We have completed our review of your Form 20-F and related filings
and have no further comments at this time.
Sincerely,
Jim B. Rosenberg
Senior Assistant Chief
Accountant
??
??
??
??
J.P. Garnier
GlaxoSmithKline PLC
October 19, 2005
Page 2 of 1
</TEXT>
</DOCUMENT>